Literature DB >> 7037830

Atypical toxin variant of Clostridium botulinum type B associated with infant botulism.

C L Hatheway, L M McCroskey, G L Lombard, V R Dowell.   

Abstract

An atypical toxin variant of Clostridium botulinum (strain 657) was isolated from the feces of a 6-week-old female infant whose symptoms and clinical history were consistent with infant botulism. Toxin detected in the feces and the toxin produced by isolates from the feces and from two rectal swabs could be neutralized by type B botulinal antitoxin only at very high ratios of of antitoxin to toxin in the neutralization mixture. One international unit of type B antitoxin neutralized only about 10 lethal doses of 657 toxin as compared with approximately 10,000 lethal doses of conventional type B toxin from the Beans strain. Antitoxin prepared against 657 toxin was 10 times more effective against the conventional toxin than against the homologous toxin. Toxoid-antitoxin-binding studies indicate that both 657 toxin and type B toxin are heterogeneous and that both toxins may contain the same molecular variants, but that the proportions of the variants are different in each.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037830      PMCID: PMC274006          DOI: 10.1128/jcm.14.6.607-611.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids.

Authors:  G G WRIGHT; J T DUFF; M A FIOCK; H B DEVLIN; R L SODERSTROM
Journal:  J Immunol       Date:  1960-04       Impact factor: 5.422

2.  Case of infant botulism in Texas.

Authors:  B J Edmond; F A Guerra; J Blake; S Hempler
Journal:  Tex Med       Date:  1977-10

3.  Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.

Authors:  T Shimizu; H Kondo
Journal:  Jpn J Med Sci Biol       Date:  1973-12

4.  Studies on strain 84 of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

5.  [Serological study of Clostridium botulinum type A and strain 84 toxins].

Authors:  A S Ciccarelli; D F Giménez
Journal:  Rev Latinoam Microbiol       Date:  1971 Apr-Jun

6.  Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases.

Authors:  M Dezfulian; V R Dowell
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

7.  Laboratory procedures for cases of suspected infant botulism.

Authors:  C L Hatheway
Journal:  Rev Infect Dis       Date:  1979 Jul-Aug
  7 in total
  15 in total

Review 1.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Recovery of a strain of Clostridium botulinum producing both neurotoxin A and neurotoxin B from canned macrobiotic food.

Authors:  G Franciosa; L Fenicia; M Pourshaban; P Aureli
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

3.  A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin.

Authors:  Susan E Maslanka; Carolina Lúquez; Janet K Dykes; William H Tepp; Christina L Pier; Sabine Pellett; Brian H Raphael; Suzanne R Kalb; John R Barr; Agam Rao; Eric A Johnson
Journal:  J Infect Dis       Date:  2015-06-10       Impact factor: 5.226

4.  Pulsotype Diversity of Clostridium botulinum Strains Containing Serotypes A and/or B Genes.

Authors:  Jessica L Halpin; Lavin Joseph; Janet K Dykes; Loretta McCroskey; Elise Smith; Denise Toney; Steven Stroika; Kelley Hise; Susan Maslanka; Carolina Lúquez
Journal:  Foodborne Pathog Dis       Date:  2017-07-10       Impact factor: 3.171

5.  Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.

Authors:  Marite Bradshaw; William H Tepp; Regina C M Whitemarsh; Sabine Pellett; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

6.  Examination of feces and serum for diagnosis of infant botulism in 336 patients.

Authors:  C L Hatheway; L M McCroskey
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

7.  Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum.

Authors:  Kristin M Marshall; Marite Bradshaw; Eric A Johnson
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence.

Authors:  S M Whelan; M J Elmore; N J Bodsworth; J K Brehm; T Atkinson; N P Minton
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

9.  Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms.

Authors:  G Franciosa; J L Ferreira; C L Hatheway
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

10.  Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains.

Authors:  Giovanna Franciosa; Antonella Maugliani; Concetta Scalfaro; Paolo Aureli
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.